期刊文献+

肠周脂肪CT征象在诊断肠疾病中的临床价值 被引量:14

Clinic value of CT signs of peri-bowels fat in diagnosing bowel diseases
下载PDF
导出
摘要 目的研究肠疾病中肠周脂肪CT征象及其病理基础,探讨肠周脂肪CT征象对诊断肠疾病的价值。方法回顾性分析经手术、病理证实的39例肠疾病患者的术前腹部CT征象,观察原发疾病与肠周脂肪CT征象的关系,并与术中所见和病理结果进行对照分析。结果39例肠疾病患者的肠周脂肪CT征象包括脂肪组织模糊、蚯蚓状影、线状影、结节影、网格状影、积液影、条索状影及脂肪组织结构僵硬,其病理基础包括充血、水肿、渗出,血管扩张、淋巴管炎、淋巴结肿大、组织纤维化、癌肿浸润。术前正确判断良、恶性36例(36/39)。肠恶性肿瘤术前CT诊断肠周淋巴结转移19例(19/20),手术病理证实只有13例(13/20)。结论肠周脂肪对肠疾病的反应敏感,不同肠疾病在肠周脂肪中产生不同的CT征象。 Objective To observe the CT characters of peri-bowels fat tissue with bowels diseases, and to explore it's clinical value in diagnosing howels diseases. Methods Abdominal CT images of 39 preoperative cases with bowels diseases con- firmed by pathology were retrospectively studied. The images characters of the lesion and peri-bowels fat tissue were observed, and the relationship between image characters with findings in operation and patho-findings were analyzed. Results The CT signs of peri bowels fat tissues of 39 cases included fatty tissue blur, angle worm sign, line sign, nodule sign, grid sign, fluidify sign, trabs sign and fatty tissue structure stiffness. The patho-findings of peri bowels fat tissues included con- gestion, edema, effusion, vessel expanding, lymphangitis, lymphadenectasis, tissue fibrosis or cancer infiltration. Preoperation exactly judged benign or malignant in 36 of 39 cases. Bowel malignant tumor was diagnosed in 19 cases (19/20) with peri-bowels lymph node metastasis preoperation, but only 13 were confirmed by operation-pathology. Conclusion Peri-bowels fat tissue is sensitive to bowels diseases. The different patho reactions of different bowels diseases results in different CT characters.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第3期462-464,共3页 Chinese Journal of Medical Imaging Technology
关键词 肠疾病 肠周脂肪 体层摄影术 X线计算机 病理 Intestinal disease Peri-bowels fat tissue Tomography, X-ray computed Pathology
  • 相关文献

参考文献14

  • 1Van Beek EA,Bakker AH,Kruyt PM,et al.Intra-and interindividual variation in gene expression in human adipose tissue.Pflugers Arch,2007,453(6):851-861.
  • 2Schffler A,Schlmerich J,Büchler C.Mechanisms of disease:adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases.Nat Clin Pract Gastroenterol Hepatol,2005,2(2):103-111.
  • 3Gambero A,Maróstica M,Abdalla Saad MJ,et al.Mesenteric adipose tissue alterations resulting from experimental reactivated colitis.Inflamm Bowel Dis,2007,13(11):1357-1364.
  • 4Hector J,Schwarzloh B,Goehring J,et al.TNF-alpha alters visfatin and adiponectin levels in human fat.Horm Metab Res,2007,39(4):250-255.
  • 5Barbier M,Vidal H,Desreumaux P,et al.Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases.Gastroenterol Clin Biol,2003,27(11):987-991.
  • 6Fanous MY,Phillips AJ,Windsor JA.Mesenteric lymph:the bridge to future management of critical illness.JOP,2007,8(4):374-399.
  • 7Ogura T,Takatsu K,Negishi R,et al.Evaluation of Intra-abdominal fat distribution using X-ray CT data for detection of rectal cancer.Nippon Hoshasen Gijutsu Gakkai Zasshi,2005,61(6):840-846.
  • 8Pereira JM,Sirlin CB,Pinto PS,et al.Disproportionate fat stranding:a helpful CT sign in patients with acute abdominal pain.Radiographics,2004,24(3):703-715.
  • 9Peyrin-Biroulet L,Chamaillard M,Gonzalez F,et al.Mesenteric fat in Crohn's disease:a pathogenetic hallmark or an innocent bystander? Gut,2007,56(4):577-583.
  • 10Wilkosz S,Epstein J,de Giorgio-Miller A,et al.Remodelling of adipose tissue during experimental omental adhesion formation.Br J Surg,2008,95(3):387-396.

二级参考文献14

  • 1[3]Harvey CJ, Amin Z, Hare CM, et al. Helical CT pneumocolon to assess colonic tumors: radiologic-pathologic correlation[J]. AJR,1998,170(6):1439-1443.
  • 2[5]Tomisaki S, Ohno S, Ichiyoshi Y, et al. Microvessel quantification and its possible relationship with liver metastasis in colorectal cancer[J]. Cancer, 1996, 77(8 Suppl):1722-1728.
  • 3[6]Weidner N. Current pathology methods for measuring intratumoral microvessel density within Brest carcinoma and other solpd tumors[J]. Breast Cancer Res Treat,1995,36(2):169-180.
  • 4[7]Inoue K, Ozeki Y, Suganuma T, et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma-association with angiogenesis and tumor progression[J]. Cancer,1997,79(2):206-213.
  • 5[8]Cheah PY, Cao X, Eu KW, et al. Nm23-H1 immunostaining is inversely associated with tumor staging but not overall survival or disease recurrence in colorectal carcinomas[J]. Br J Cancer,1998,77(7):1164-1168.
  • 6Lawrence FB,Brygida B,Robert WR,et al.Increased expression of vascular permeability factor (Vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma[J].AJP,1993,143(5):1255-1262.
  • 7Ryuji Maekawa,Hideo Naki,Hiroshi Yoshida,et al.Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalamine hydroxiamic acid(BPHA),an orally-active,selective matrix metalloproteinase inhibitor[J].Cancer Res,1999,59(6):1231-1235.
  • 8Lee JC,Chow NH,Wang ST,et al.Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients[J].Eur J Cancer,2000,36(6):748-753.
  • 9Miles KA,Hayball MP,Dixon AK.Functional imaging of hepatic perfusion obtained with dynamic CT[J].Radiology,1993,188(2):405-411.
  • 10Dolorme S,Knopp MV.Non-invasive vascular imaging: assessing tumor vascularity[J].Eur Radiol,1988,8(4):517-527.

共引文献10

同被引文献125

引证文献14

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部